GCTK
Glucotrack, Inc.
Key Financials
Operating Income
$-16090000
↓ 10.6%
Revenue
$208762
↑ 0.4%
Net Income
$-19388000
↑ 14.2%
Total Liabilities
$5.0M
↓ 73.5%
Total Assets
$7.8M
↑ 32.1%
Cash & Equivalents
$7.4M
↑ 31.4%
Shareholders' Equity
$2.8M
↑ 121.8%
EPS (Diluted)
$31.22
↓ 54.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| DEF 14A | 8/10/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| PRE 14A | 7/31/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 8-K/A | 7/29/2026 | View on SEC |
| 8-K | 7/27/2026 | View on SEC |
| ARS | 7/17/2026 | View on SEC |
| DEF 14A | 7/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GCTK |
| Company Name | Glucotrack, Inc. |
| CIK | 1506983 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 972 (8) 675-7878 |